Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Mylan’s President, Emcure’s CEO named in US drug price-fixing probe; Novartis buys French biotech for US$ 3.9 billion
This week in Phispers, we look at how Mylan’s president Rajiv Malik and Emcure’s CEO Sat
India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017
A review of the Drug Master Files (DMFs) submitted to the United
States Food and Drug Administration